#Global

A roundup of POZ’s reporting on studies presented at the Mexico City conference about HIV treatment, vaccines, PrEP and other concerns.

Swiss researchers analyzed shifts in kidney function among those switching from the old form of the HIV medication to the new one.

Australia has led the world in an aggressive push to provide its citizens with low-cost treatment for the virus.

Help find the “missing millions” who don’t know they’re living with viral hepatitis.

An analysis conducted in Taiwan analyzed health outcomes over more than a decade.

Researchers found that this association was statistically significant beginning five years after treatment.

Researchers analyzed health data regarding modern hep C treatments specific to New South Wales.

Such a vaccine would make inoculation easier in developing nations, where the need is great.

The World Health Organization has set various benchmarks for nations to hit in controlling their epidemics by 2030.

The nation has provided unrestricted access to hepatitis C treatment since 2016.

Researchers conducted an analysis of hep C treatment outcomes in those also living with HIV in Western nations.

Traditionally hep C transmits sexually mostly among HIV-positive men who have sex with men.

Researchers followed a group of teenagers over time and found that their rate of non-alcoholic fatty liver disease rose in young adulthood.

This finding is from a program that sought to provide blanket treatment to Iceland’s hep C population.

Researchers followed nearly 10,000 people with hepatitis C, some of whom were treated with direct-acting antivirals.

Researchers believe that hepatitis C is spreading through sex from the HIV-positive population to those who don’t have HIV.